Skip to main content
Top
Published in: International Journal of Clinical Oncology 3/2015

01-06-2015 | Original Article

Pregnancy does not increase the local recurrence rate after surgical resection of desmoid-type fibromatosis

Author: Justin. M. M. Cates

Published in: International Journal of Clinical Oncology | Issue 3/2015

Login to get access

Abstract

Background

Pregnancy has been reported as a risk factor for promoting growth and progression of desmoid-type fibromatosis because of the presumed role of estrogens in stimulating desmoid growth. In this study, the clinical outcomes of females who were pregnant 5 years or less before resection of desmoid tumor or who became pregnant after resection were compared to nulliparous females or females who were pregnant more than 5 years before resection.

Methods

Obstetric histories of desmoid tumor patients were abstracted from medical records. Patients were grouped by pregnancy status as either: pregnancy-associated (pregnant up to 5 years before primary desmoid tumor resection or pregnant after resection) or not pregnancy-associated (nulliparous or pregnant more than 5 years before resection of desmoid tumor). Cox proportional hazards regression was used to evaluate pregnancy status as a predictor of desmoid tumor recurrence.

Results

There were 15 females who had pregnancy-associated desmoids (33 %) and 31 females who had non-pregnancy-associated desmoids (67 %). There were no differences in clinicopathologic features or recurrence-free survival between females of different pregnancy status in univariate or multivariate survival analyses.

Conclusion

Recurrence-free survival rates among women recently pregnant before or pregnant after resection of desmoid tumor and nulliparous women or those with a remote history of pregnancy are comparable after adjusting for patient age, anatomic location, and completeness of surgical resection. Subsequent pregnancy should not be discouraged for reproductive-aged women after resection of desmoid-type fibromatosis.
Literature
1.
go back to reference Sturt NJ, Gallagher MC, Bassett P et al (2004) Evidence for genetic predisposition to desmoid tumours in familial adenomatous polyposis independent of the germline APC mutation. Gut 53:1832–1836PubMedCentralPubMedCrossRef Sturt NJ, Gallagher MC, Bassett P et al (2004) Evidence for genetic predisposition to desmoid tumours in familial adenomatous polyposis independent of the germline APC mutation. Gut 53:1832–1836PubMedCentralPubMedCrossRef
2.
go back to reference Reitamo JJ, Scheinin TM, Häyry P (1986) The desmoid syndrome: new aspects in the cause, pathogenesis and treatment of the desmoid tumor. Am J Surg 151:230–237PubMedCrossRef Reitamo JJ, Scheinin TM, Häyry P (1986) The desmoid syndrome: new aspects in the cause, pathogenesis and treatment of the desmoid tumor. Am J Surg 151:230–237PubMedCrossRef
3.
go back to reference Knudsen AL, Bulow S (2001) Desmoid tumour in familial adenomatous polyposis. A review of literature. Fam Cancer 1:111–119PubMedCrossRef Knudsen AL, Bulow S (2001) Desmoid tumour in familial adenomatous polyposis. A review of literature. Fam Cancer 1:111–119PubMedCrossRef
4.
5.
go back to reference Rock MG, Pritchard DJ, Reiman HM et al (1984) Extra-abdominal desmoid tumors. J Bone Joint Surg Am 66:1369–1374PubMed Rock MG, Pritchard DJ, Reiman HM et al (1984) Extra-abdominal desmoid tumors. J Bone Joint Surg Am 66:1369–1374PubMed
6.
go back to reference Häyry P, Reitamo JJ, Tötterman S et al (1982) The desmoid tumor. II. Analysis of factors possibly contributing to the etiology and growth behavior. Am J Clin Pathol 77:674–680PubMed Häyry P, Reitamo JJ, Tötterman S et al (1982) The desmoid tumor. II. Analysis of factors possibly contributing to the etiology and growth behavior. Am J Clin Pathol 77:674–680PubMed
7.
go back to reference de Bree E, Keus R, Melissas J et al (2009) Desmoid tumors: need for an individualized approach. Expert Rev Anticancer Ther 9:525–535PubMedCrossRef de Bree E, Keus R, Melissas J et al (2009) Desmoid tumors: need for an individualized approach. Expert Rev Anticancer Ther 9:525–535PubMedCrossRef
8.
go back to reference Clark SK, Neale KF, Landgrebe JC et al (1999) Desmoid tumours complicating familial adenomatous polyposis. Br J Surg 86:1185–1189PubMedCrossRef Clark SK, Neale KF, Landgrebe JC et al (1999) Desmoid tumours complicating familial adenomatous polyposis. Br J Surg 86:1185–1189PubMedCrossRef
9.
go back to reference Soravia C, Berk T, McLeod RS et al (2000) Desmoid disease in patients with familial adenomatous polyposis. Dis Colon Rectum 43:363–369PubMedCrossRef Soravia C, Berk T, McLeod RS et al (2000) Desmoid disease in patients with familial adenomatous polyposis. Dis Colon Rectum 43:363–369PubMedCrossRef
10.
go back to reference Waddell WR, Kirsch WM (1991) Testolactone, sulindac, warfarin, and vitamin K1 for unresectable desmoid tumors. Am J Surg 161:416–421PubMedCrossRef Waddell WR, Kirsch WM (1991) Testolactone, sulindac, warfarin, and vitamin K1 for unresectable desmoid tumors. Am J Surg 161:416–421PubMedCrossRef
11.
go back to reference Rocha FG, George S, Fletcher C, et al (2008) Pregnancy-associated desmoid tumors: a distinct clinical entity. Ann Surg Oncol 15:66 (abstract) Rocha FG, George S, Fletcher C, et al (2008) Pregnancy-associated desmoid tumors: a distinct clinical entity. Ann Surg Oncol 15:66 (abstract)
12.
go back to reference Nieuwenhuis MH, De Vos Tot Nederveen Cappel W, Botma A et al (2008) Desmoid tumors in a Dutch cohort of patients with familial adenomatous polyposis. Clin Gastroenterol Hepatol 6:215–219PubMedCrossRef Nieuwenhuis MH, De Vos Tot Nederveen Cappel W, Botma A et al (2008) Desmoid tumors in a Dutch cohort of patients with familial adenomatous polyposis. Clin Gastroenterol Hepatol 6:215–219PubMedCrossRef
13.
go back to reference Salas S, Dufresne A, Bui B et al (2011) Prognostic factors influencing progression-free survival determined from a series of sporadic desmoid tumors: a wait-and-see policy according to tumor presentation. J Clin Oncol 29:3553–3558PubMedCrossRef Salas S, Dufresne A, Bui B et al (2011) Prognostic factors influencing progression-free survival determined from a series of sporadic desmoid tumors: a wait-and-see policy according to tumor presentation. J Clin Oncol 29:3553–3558PubMedCrossRef
14.
go back to reference Schiessling S, Kihm M, Ganschow P et al (2013) Desmoid tumour biology in patients with familial adenomatous polyposis coli. Br J Surg 100:694–703PubMedCrossRef Schiessling S, Kihm M, Ganschow P et al (2013) Desmoid tumour biology in patients with familial adenomatous polyposis coli. Br J Surg 100:694–703PubMedCrossRef
15.
go back to reference Fiore M, Coppola S, Cannell AJ et al (2013) Desmoid-type fibromatosis and pregnancy: a multi-institutional analysis of recurrence and obstetric risk. Ann Surg 259:973–978CrossRef Fiore M, Coppola S, Cannell AJ et al (2013) Desmoid-type fibromatosis and pregnancy: a multi-institutional analysis of recurrence and obstetric risk. Ann Surg 259:973–978CrossRef
16.
go back to reference de Bree E, Dimitriadis E, Giannikaki E et al (2013) A giant pregnancy-associated intra-abdominal desmoid tumour: not necessarily a contraindication for subsequent pregnancy. World J Surg Oncol 11:277PubMedCentralPubMedCrossRef de Bree E, Dimitriadis E, Giannikaki E et al (2013) A giant pregnancy-associated intra-abdominal desmoid tumour: not necessarily a contraindication for subsequent pregnancy. World J Surg Oncol 11:277PubMedCentralPubMedCrossRef
17.
go back to reference Baumert BG, Spahr MO, Von Hochstetter A et al (2007) The impact of radiotherapy in the treatment of desmoid tumours. An international survey of 110 patients. A study of the Rare Cancer Network. Radiat Oncol 2:12PubMedCentralPubMedCrossRef Baumert BG, Spahr MO, Von Hochstetter A et al (2007) The impact of radiotherapy in the treatment of desmoid tumours. An international survey of 110 patients. A study of the Rare Cancer Network. Radiat Oncol 2:12PubMedCentralPubMedCrossRef
18.
go back to reference Mulik V, Griffiths AN, Beattie RB (2003) Desmoid tumours with familial adenomatous polyposis in pregnancy. J Obstet Gynaecol 23:307–308PubMedCrossRef Mulik V, Griffiths AN, Beattie RB (2003) Desmoid tumours with familial adenomatous polyposis in pregnancy. J Obstet Gynaecol 23:307–308PubMedCrossRef
19.
go back to reference Robinson WA, McMillan C, Kendall A et al (2012) Desmoid tumors in pregnant and postpartum women. Cancers (Basel) 4:184–192CrossRef Robinson WA, McMillan C, Kendall A et al (2012) Desmoid tumors in pregnant and postpartum women. Cancers (Basel) 4:184–192CrossRef
20.
go back to reference Church JM, McGannon E (2000) Prior pregnancy ameliorates the course of intra-abdominal desmoid tumors in patients with familial adenomatous polyposis. Dis Colon Rectum 43:445–450PubMedCrossRef Church JM, McGannon E (2000) Prior pregnancy ameliorates the course of intra-abdominal desmoid tumors in patients with familial adenomatous polyposis. Dis Colon Rectum 43:445–450PubMedCrossRef
21.
go back to reference Heiskanen I, Jarvinen HJ (1996) Occurrence of desmoid tumours in familial adenomatous polyposis and results of treatment. Int J Colorectal Dis 11:157–162PubMedCrossRef Heiskanen I, Jarvinen HJ (1996) Occurrence of desmoid tumours in familial adenomatous polyposis and results of treatment. Int J Colorectal Dis 11:157–162PubMedCrossRef
22.
go back to reference Way JC, Culham BA (1999) Desmoid tumour. The risk of recurrent or new disease with subsequent pregnancy: a case report. Can J Surg 42:51–54PubMedCentralPubMed Way JC, Culham BA (1999) Desmoid tumour. The risk of recurrent or new disease with subsequent pregnancy: a case report. Can J Surg 42:51–54PubMedCentralPubMed
23.
go back to reference Johner A, Tiwari P, Zetler P et al (2009) Abdominal wall desmoid tumors associated with pregnancy: current concepts. Expert Rev Anticancer Ther 9:1675–1682PubMedCrossRef Johner A, Tiwari P, Zetler P et al (2009) Abdominal wall desmoid tumors associated with pregnancy: current concepts. Expert Rev Anticancer Ther 9:1675–1682PubMedCrossRef
24.
go back to reference Mignemi NA, Itani DM, Fasig JH et al (2012) Signal transduction pathway analysis in desmoid-type fibromatosis: transforming growth factor-beta, COX2 and sex steroid receptors. Cancer Sci 103:2173–2180PubMedCentralPubMedCrossRef Mignemi NA, Itani DM, Fasig JH et al (2012) Signal transduction pathway analysis in desmoid-type fibromatosis: transforming growth factor-beta, COX2 and sex steroid receptors. Cancer Sci 103:2173–2180PubMedCentralPubMedCrossRef
25.
go back to reference Ishizuka M, Hatori M, Dohi O et al (2006) Expression profiles of sex steroid receptors in desmoid tumors. Tohoku J Exp Med 210:189–198PubMedCrossRef Ishizuka M, Hatori M, Dohi O et al (2006) Expression profiles of sex steroid receptors in desmoid tumors. Tohoku J Exp Med 210:189–198PubMedCrossRef
26.
go back to reference Deyrup AT, Tretiakova M, Montag AG (2006) Estrogen receptor-beta expression in extra abdominal fibromatoses: an analysis of 40 cases. Cancer 106:208–213PubMedCrossRef Deyrup AT, Tretiakova M, Montag AG (2006) Estrogen receptor-beta expression in extra abdominal fibromatoses: an analysis of 40 cases. Cancer 106:208–213PubMedCrossRef
27.
go back to reference Sørensen A, Keller J, Nielsen OS et al (2002) Treatment of aggressive fibromatosis: a retrospective study of 72 patients followed for 1–27 years. Acta Orthop Scand 73:213–219PubMedCrossRef Sørensen A, Keller J, Nielsen OS et al (2002) Treatment of aggressive fibromatosis: a retrospective study of 72 patients followed for 1–27 years. Acta Orthop Scand 73:213–219PubMedCrossRef
28.
go back to reference Uhlen M, Oksvold P, Fagerberg L et al (2010) Towards a knowledge-based Human Protein Atlas. Nat Biotechnol 28:1248–1250PubMedCrossRef Uhlen M, Oksvold P, Fagerberg L et al (2010) Towards a knowledge-based Human Protein Atlas. Nat Biotechnol 28:1248–1250PubMedCrossRef
29.
go back to reference Bocale D, Rotelli MT, Cavallini A et al (2011) Anti-oestrogen therapy in the treatment of desmoid tumours: a systematic review. Colorectal Dis 13:e388–e395PubMedCrossRef Bocale D, Rotelli MT, Cavallini A et al (2011) Anti-oestrogen therapy in the treatment of desmoid tumours: a systematic review. Colorectal Dis 13:e388–e395PubMedCrossRef
30.
go back to reference Janinis J, Patriki M, Vini L et al (2003) The pharmacological treatment of aggressive fibromatosis: a systematic review. Ann Oncol 14:181–190PubMedCrossRef Janinis J, Patriki M, Vini L et al (2003) The pharmacological treatment of aggressive fibromatosis: a systematic review. Ann Oncol 14:181–190PubMedCrossRef
31.
go back to reference Hong H, Nadesan P, Poon R et al (2011) Testosterone regulates cell proliferation in aggressive fibromatosis (desmoid tumour). Br J Cancer 104:1452–1458PubMedCentralPubMedCrossRef Hong H, Nadesan P, Poon R et al (2011) Testosterone regulates cell proliferation in aggressive fibromatosis (desmoid tumour). Br J Cancer 104:1452–1458PubMedCentralPubMedCrossRef
32.
go back to reference Amir AL, Barua M, McKnight NC et al (2003) A direct beta-catenin-independent interaction between androgen receptor and T cell factor 4. J Biol Chem 278:30828–30834PubMedCrossRef Amir AL, Barua M, McKnight NC et al (2003) A direct beta-catenin-independent interaction between androgen receptor and T cell factor 4. J Biol Chem 278:30828–30834PubMedCrossRef
33.
go back to reference Kang HY, Huang KE, Chang SY et al (2002) Differential modulation of androgen receptor-mediated transactivation by Smad3 and tumor suppressor Smad4. J Biol Chem 277:43749–43756PubMedCrossRef Kang HY, Huang KE, Chang SY et al (2002) Differential modulation of androgen receptor-mediated transactivation by Smad3 and tumor suppressor Smad4. J Biol Chem 277:43749–43756PubMedCrossRef
34.
go back to reference Lev D, Kotilingam D, Wei C et al (2007) Optimizing treatment of desmoid tumors. J Clin Oncol 25:1785–1791PubMedCrossRef Lev D, Kotilingam D, Wei C et al (2007) Optimizing treatment of desmoid tumors. J Clin Oncol 25:1785–1791PubMedCrossRef
Metadata
Title
Pregnancy does not increase the local recurrence rate after surgical resection of desmoid-type fibromatosis
Author
Justin. M. M. Cates
Publication date
01-06-2015
Publisher
Springer Japan
Published in
International Journal of Clinical Oncology / Issue 3/2015
Print ISSN: 1341-9625
Electronic ISSN: 1437-7772
DOI
https://doi.org/10.1007/s10147-014-0743-x

Other articles of this Issue 3/2015

International Journal of Clinical Oncology 3/2015 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine